Works matching IS 13518216 AND DT 2009 AND VI 15 AND IP 3

Results: 32

Current approaches in haemophilic arthropathy of the hip.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 659, doi. 10.1111/j.1365-2516.2007.01563.x

By:

MANN, H. A.;
CHOUDHURY, M. Z. B.;
ALLEN, D. J.;
LEE, C. A.;
GODDARD, N. J.

Publication type:

Article

IL-1β, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 802, doi. 10.1111/j.1365-2516.2008.01973.x

By:

ØVLISEN, K.;
KRISTENSEN, A. T.;
JENSEN, A. L.;
TRANHOLM, M.

Publication type:

Article

The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.

Published in:

2009

By:

DUNKLEY, S. M.;
YANG, K.

Publication type:

Letter

About the rarity of haemoptysis in congenital bleeding disorders. A report of five cases.

Published in:

2009

By:

GIROLAMI, A.;
VETTORE, S.;
SCANDELLARI, R.;
ALLEMAND, E.;
GIROLAMI, B.

Publication type:

Letter

Experience with a third generation recombinant factor VIII concentrate (Advate®) for immune tolerance induction in patients with haemophilia A.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 718, doi. 10.1111/j.1365-2516.2008.01960.x

By:

VALENTINO, L. A.;
RECHT, M.;
DIPAOLA, J.;
SHAPIRO, A. D.;
PIPE, S. W.;
EWING, N.;
URGO, J.;
BULLOCK, T.;
SIMMONS, M.;
DEGUZMAN, C.

Publication type:

Article

Activated prothrombin complex concentrate for acquired haemophilia when recombinant factor VIIa fails.

Published in:

2009

By:

HUSSEIN, Z.;
KUDVA, G. C.;
REIMERS, H. J.

Publication type:

Letter

Single-dose (270 μg kg−1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 760, doi. 10.1111/j.1365-2516.2008.01968.x

By:

PAN-PETESCH, B.;
LAGUNA, P.;
MITAL, A.;
STANLEY, J.;
TORCHET, M. F.;
SALEK, S. Z.;
SALAJ, P.

Publication type:

Article

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 639, doi. 10.1111/j.1365-2516.2008.01950.x

By:

HERMANS, C.;
ALTISENT, C.;
BATOROVA, A.;
CHAMBOST, H.;
DE MOERLOOSE, P.;
KARAFOULIDOU, A.;
KLAMROTH, R.;
RICHARDS, M.;
WHITE, B.;
DOLAN, G.

Publication type:

Article

Identification of de novo deletion in the factor VIII gene by MLPA technique in two girls with isolated factor VIII deficiency.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 797, doi. 10.1111/j.1365-2516.2008.01974.x

By:

LANNOY, N.;
ABINET, I.;
DAHAN, K.;
HERMANS, C.

Publication type:

Article

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 676, doi. 10.1111/j.1365-2516.2008.01978.x

By:

MARTINOWITZ, U.;
LUBOSHITZ, J.;
BASHARI, D.;
RAVID, B.;
GORINA, E.;
REGAN, L.;
STASS, H.;
LUBETSKY, A.

Publication type:

Article

The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 733, doi. 10.1111/j.1365-2516.2009.01980.x

By:

VALENTINO, L. A.

Publication type:

Article

Registered nurses for the home treatment of children with haemophilia who have developed inhibitors: a case report.

Published in:

2009

By:

SANTORO, R.;
MARINO, R.;
DIZIONE, L.;
IANNACCARO, P.

Publication type:

Letter

Physical activity participation and bleeding characteristics in young patients with severe haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 695, doi. 10.1111/j.1365-2516.2009.01990.x

By:

TIKTINSKY, R.;
KENET, G.;
DVIR, Z.;
FALK, B.;
HEIM, M.;
MARTINOWITZ, U.;
KATZ-LEURER, M.

Publication type:

Article

Arthroscopic synovectomies combined with reduced weight-bearing using patella tendon-bearing braces were very effective for progressed haemophilic ankle arthropathy in three paediatric patients.

Published in:

2009

By:

TANAKA, Y.;
SHINOHARA, Y.;
NARIKAWA, K.;
KUMAI, T.;
TAKAKURA, Y.;
SAKURAI, Y.;
TANAKA, I.;
SHIMA, M.;
YOSHIOKA, A.

Publication type:

Letter

The outcome of cementless total hip arthroplasty in haemophilic hip arthropathy.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 766, doi. 10.1111/j.1365-2516.2009.01986.x

By:

YOO, M. C.;
CHO, Y. J.;
KIM, K. I.;
RAMTEKE, A.;
CHUN, Y. S.

Publication type:

Article

Severe gastrointestinal haemorrhage, first manifestation of neonatal haemophilia A.

Published in:

2009

By:

PICCIN, A.;
O'MARCAIGH, A.;
DEIRATANY, S.;
MC MAHON, C.;
SMITH, O. P.

Publication type:

Letter

Surgical treatment of arteriovenous malformation in a child with haemophilia.

Published in:

2009

By:

ALEXIOU, GEORGE A.;
GEORGOULIS, GEORGE;
SFAKIANOS, GEORGE;
PRODROMOU, NEOFYTOS

Publication type:

Letter

Inattention, hyperactivity-impulsivity, academic skills and psychopathology in boys with and without haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 701, doi. 10.1111/j.1365-2516.2009.01993.x

By:

SPENCER, M. L. S.;
WODRICH, D. L.;
SCHULTZ, W.;
WAGNER, L.;
RECHT, M.

Publication type:

Article

Performance of recalibrated ReFacto® laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto® (B-domain deleted recombinant factor VIII)

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 779, doi. 10.1111/j.1365-2516.2009.01983.x

By:

SANTORO, C.;
IORIO, A.;
FERRANTE, F.;
PALLOTTA, A.;
PIGNOLONI, P.;
BIONDO, F.;
AGNELLI, G.;
MAZZUCCONI, M. G.

Publication type:

Article

Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 788, doi. 10.1111/j.1365-2516.2009.01995.x

By:

ZHUKOV, O.;
POPOV, J.;
RAMOS, R.;
VAUSE, C.;
RUDEN, S.;
SFERRUZZA, A.;
DLOTT, J.;
SAHUD, M.

Publication type:

Article

DDAVP for von Willebrand menorrhagia – severe hyponatraemia, haemolysis, seizure, coma.!!Caution.

Published in:

2009

By:

OLOWOKURE, O.;
FISHMAN, M.;
CROMWELL, C.;
ALEDORT, L.

Publication type:

Letter

Discordant antibody response in monozygotic twins with severe haemophilia A caused by intensive treatment.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 712, doi. 10.1111/j.1365-2516.2009.01998.x

By:

GOUW, S. C.;
TER AVEST, P. C.;
VAN HELDEN, P. M.;
VOORBERG, J.;
van den BERG, H. M.

Publication type:

Article

Recovery of recombinant factor IX determined in clinical practice.

Published in:

2009

By:

MARTORELL, M.;
ALTISENT, C.;
PARRA, R.

Publication type:

Letter

Haemophilia in Spain.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 665, doi. 10.1111/j.1365-2516.2009.02001.x

By:

AZNAR, J. A.;
LUCÍA, F.;
ABAD-FRANCH, L.;
JIMÉNEZ-YUSTE, V.;
PÉREZ, R.;
BATLLE, J.;
BALDA, I.;
PARRA, R.;
CORTINA, V. R.

Publication type:

Article

Assessment of incidence of inhibitors in patients with haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 707, doi. 10.1111/j.1365-2516.2009.02002.x

By:

VAN DER BOM, J. G.;
TER AVEST, P.;
VAN DEN BERG, H. M.;
PSATY, B. M.;
WEISS, N. S.

Publication type:

Article

Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 774, doi. 10.1111/j.1365-2516.2009.02004.x

By:

LANDAU, D.;
ROSENBERG, N.;
ZIVELIN, A.;
STARETZ-CHACHAM, O.;
KAPELUSHNIK, J.

Publication type:

Article

Participation and risk-taking behaviour in sports in children with haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 686, doi. 10.1111/j.1365-2516.2009.02006.x

By:

KÖITER, J.;
VAN GENDEREN, F. R.;
BRONS, P. P. T.;
NIJHUIS-VAN DER SANDEN, M. W. G.

Publication type:

Article

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 752, doi. 10.1111/j.1365-2516.2009.02007.x

By:

SALAJ, P.;
BRABEC, P.;
PENKA, M.;
POHLREICHOVA, V.;
SMEJKAL, P.;
CETKOVSKY, P.;
DUSEK, L.;
HEDNER, U.

Publication type:

Article

Gene therapy for haemophilia...yes, but...with non-viral vectors?

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 811, doi. 10.1111/j.1365-2516.2009.02010.x

By:

LIRAS, A.;
OLMEDILLAS, S.

Publication type:

Article

Response to the DDAVP test in a patient with combined deficiency of factor V and factor VIII.

Published in:

2009

By:

GUGLIELMONE, H.;
MINOLDO, S.;
JARCHUM, G.

Publication type:

Letter

FEIBA® in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 743, doi. 10.1111/j.1365-2516.2009.02012.x

By:

SMEJKAL, P.;
BRABEC, P.;
MATYSKOVA, M.;
BULIKOVA, A.;
SLECHTOVA, M.;
KISSOVA, J.;
CHLUPOVA, G.;
MUZIK, J.;
PENKA, M.

Publication type:

Article

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience.

Published in:

Haemophilia, 2009, v. 15, n. 3, p. 727, doi. 10.1111/j.1365-2516.2009.02017.x

By:

HOLME, P. A.;
GLOMSTEIN, A.;
GRØNHAUG, S.;
TJØNNFJORD, G. E.

Publication type:

Article

Works matching IS 13518216 AND DT 2009 AND VI 15 AND IP 3

Current approaches in haemophilic arthropathy of the hip.

IL-1β, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis.

The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.

About the rarity of haemoptysis in congenital bleeding disorders. A report of five cases.

Experience with a third generation recombinant factor VIII concentrate (Advate<sup>®</sup>) for immune tolerance induction in patients with haemophilia A.

Activated prothrombin complex concentrate for acquired haemophilia when recombinant factor VIIa fails.

Single-dose (270 μg kg<sup>−1</sup>) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres.

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations.

Identification of de novo deletion in the factor VIII gene by MLPA technique in two girls with isolated factor VIII deficiency.

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.

The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.

Registered nurses for the home treatment of children with haemophilia who have developed inhibitors: a case report.

Physical activity participation and bleeding characteristics in young patients with severe haemophilia.

Arthroscopic synovectomies combined with reduced weight-bearing using patella tendon-bearing braces were very effective for progressed haemophilic ankle arthropathy in three paediatric patients.

The outcome of cementless total hip arthroplasty in haemophilic hip arthropathy.

Severe gastrointestinal haemorrhage, first manifestation of neonatal haemophilia A.

Surgical treatment of arteriovenous malformation in a child with haemophilia.

Inattention, hyperactivity-impulsivity, academic skills and psychopathology in boys with and without haemophilia.

Performance of recalibrated ReFacto<sup>®</sup> laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto<sup>®</sup> (B-domain deleted recombinant factor VIII)

Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.

DDAVP for von Willebrand menorrhagia – severe hyponatraemia, haemolysis, seizure, coma.!!Caution.

Discordant antibody response in monozygotic twins with severe haemophilia A caused by intensive treatment.

Recovery of recombinant factor IX determined in clinical practice.

Haemophilia in Spain.

Assessment of incidence of inhibitors in patients with haemophilia.

Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation.

Participation and risk-taking behaviour in sports in children with haemophilia.

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.

Gene therapy for haemophilia...yes, but...with non-viral vectors?

Response to the DDAVP test in a patient with combined deficiency of factor V and factor VIII.

FEIBA<sup>®</sup> in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre.

Home treatment with bypassing products in inhibitor patients: a 7.5-year experience.